COGNEX CORP
CGNXNASDAQ🏆 #896 by market capEarnings Oct 29US Equity
$59.67▲ $0.94 (+1.57%)
🌙 After hours$59.69▲ 0.03%Regular close · extended-hours price shownTrack CGNX
Get earnings, price moves & breaking news on Telegram
24h▲ 1.6%
7d▲ 1.2%
14d▲ 0.9%
30d▼ 1.3%
ytd▲ 65.8%
1y▲ 31.1%
🏦Market Cap
$9.93B
Small Cap
📈Revenue Growth (YoY)
+17.1%
Healthy
📊Gross Margin
68.9%
High
💵FCF Margin
24.6%
Strong
⚖️P/S Ratio
9.0x
Elevated
Otter Score
60
Fair
COGNEX CORP
CGNXAnalyst Ratings
Price
$59.67
Total
32
Raised
5
Lowered
5
Avg PT
$75.73
H / L
$91 / $65
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
DA Davidson | Reiterated | Neutral | 2026-09-23 | $65.00 | +8.90% |
Baird | Reiterated | Neutral | 2026-09-23 | — | — |
Needham | Reiterated | Buy | 2026-09-15 | $75.00 | +25.70% |
Barclays | Reiterated | Overweight | 2026-08-10 | $80.00 | +34.10% |
HSBC | Downgraded | Buy → Hold | 2026-08-10 | $65.00 | +8.90% |
Cantor Fitzgerald | Reiterated | Overweight | 2026-08-07 | $84.00 | +40.80% |
Citigroup | Reiterated | Neutral | 2026-08-07 | — | — |
Truist Securities | Reiterated | Hold | 2026-08-07 | — | — |
JP Morgan | Upgraded | Neutral → Overweight | 2026-05-26 | — | — |
Goldman Sachs | Reiterated | Buy | 2026-05-11 | $91.00 | +52.50% |
Stephens & Co. | Reiterated | Overweight | 2026-05-07 | — | — |
Keybanc | Reiterated | Overweight | 2026-02-13 | $70.00 | +17.30% |
UBS | Reiterated | Buy | 2025-08-01 | $75.00 | +25.70% |
Bernstein | Reiterated | Outperform | 2024-05-03 | $75.00 | +25.70% |
Raymond James | Reiterated | Strong Buy | 2023-11-06 | $75.00 | +25.70% |
Credit Suisse | Reiterated | Neutral | 2023-08-07 | $41.00 | −31.30% |
Morgan Stanley | Reiterated | Underweight | 2023-08-04 | — | — |
Northcoast Research | Downgraded | Buy → Neutral | 2023-02-01 | — | — |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2022-11-22 | — | — |
Daiwa Capital | Upgraded | Neutral → Outperform | 2022-01-25 | — | — |
Gordon Haskett | Reiterated | Hold | 2019-04-17 | — | — |
Canaccord Genuity | Reiterated | Hold | 2018-02-15 | — | — |
Wolfe Research | Reiterated | Peer Perform → Perform | 2017-07-11 | — | — |
Deutsche Bank | Reiterated | Buy | 2016-12-08 | — | — |
CLSA | Upgraded | Underperform → Outperform | 2016-11-07 | — | — |
FBR Capital | Reiterated | Market Perform → Perform | 2016-05-11 | — | — |
CSLA | Downgraded | Outperform → Underperform | 2016-03-24 | — | — |
Nomura | Reiterated | Buy | 2015-09-17 | — | — |
Oppenheimer | Downgraded | Outperform → Perform | 2015-04-23 | — | — |
BB&T Capital | Reiterated | Buy | 2013-12-18 | — | — |
Piper Sandler | Upgraded | Underweight → Neutral | 2013-09-11 | — | — |
PiperJaffray | Upgraded | Underweight → Neutral | 2013-09-11 | — | — |
Institution
DA Davidson
Reiterated · Neutral · 2026-09-23
$65.00
+8.90%
Baird
Reiterated · Neutral · 2026-09-23
—
—
Needham
Reiterated · Buy · 2026-09-15
$75.00
+25.70%
Barclays
Reiterated · Overweight · 2026-08-10
$80.00
+34.10%
HSBC
Downgraded · Buy → Hold · 2026-08-10
$65.00
+8.90%
Cantor Fitzgerald
Reiterated · Overweight · 2026-08-07
$84.00
+40.80%
Citigroup
Reiterated · Neutral · 2026-08-07
—
—
Truist Securities
Reiterated · Hold · 2026-08-07
—
—
JP Morgan
Upgraded · Neutral → Overweight · 2026-05-26
—
—
Goldman Sachs
Reiterated · Buy · 2026-05-11
$91.00
+52.50%
Stephens & Co.
Reiterated · Overweight · 2026-05-07
—
—
Keybanc
Reiterated · Overweight · 2026-02-13
$70.00
+17.30%
UBS
Reiterated · Buy · 2025-08-01
$75.00
+25.70%
Bernstein
Reiterated · Outperform · 2024-05-03
$75.00
+25.70%
Raymond James
Reiterated · Strong Buy · 2023-11-06
$75.00
+25.70%
Credit Suisse
Reiterated · Neutral · 2023-08-07
$41.00
−31.30%
Morgan Stanley
Reiterated · Underweight · 2023-08-04
—
—
Northcoast Research
Downgraded · Buy → Neutral · 2023-02-01
—
—
Cowen & Co.
Downgraded · Outperform → Market Perform · 2022-11-22
—
—
Daiwa Capital
Upgraded · Neutral → Outperform · 2022-01-25
—
—
Gordon Haskett
Reiterated · Hold · 2019-04-17
—
—
Canaccord Genuity
Reiterated · Hold · 2018-02-15
—
—
Wolfe Research
Reiterated · Peer Perform → Perform · 2017-07-11
—
—
Deutsche Bank
Reiterated · Buy · 2016-12-08
—
—
CLSA
Upgraded · Underperform → Outperform · 2016-11-07
—
—
FBR Capital
Reiterated · Market Perform → Perform · 2016-05-11
—
—
CSLA
Downgraded · Outperform → Underperform · 2016-03-24
—
—
Nomura
Reiterated · Buy · 2015-09-17
—
—
Oppenheimer
Downgraded · Outperform → Perform · 2015-04-23
—
—
BB&T Capital
Reiterated · Buy · 2013-12-18
—
—
Piper Sandler
Upgraded · Underweight → Neutral · 2013-09-11
—
—
PiperJaffray
Upgraded · Underweight → Neutral · 2013-09-11
—
—
One row per institution · price target from the firm's latest published target